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A b stra ct
Background: The W AVE/SCAR complex, consisting of CYFIP (PIRI2I or Sral), Kette (Napl), 
Abi, SCAR (WAVE) and HSPC300, is known to regulate the actin nucleating Arp2/3 complex in a 
Racl-dependent manner. While in vitro and in vivo studies have demonstrated that CYFIP, Kette, 
Abi and SCAR work as subunits of the complex, the role of the small protein HSPC300 remains 
unclear.
Results: In the present study, we identify the HSPC300 gene and characterize its interaction with 
the W AVE/SCAR complex in the Drosophila animal model. On the basis of several lines of evidence, 
we demonstrate that HSPC300 is an indispensable component of the complex controlling axonal 
and neuromuscular junction (NMJ) growth. First, the Drosophila HSPC300 expression profile 
resembles that of other members of the WAVE/SCAR complex. Second, HSPC300 mutation, as 
well as mutations in the other complex subunits, results in identical axonal and NMJ growth defects. 
Third, like with other complex subunits, defects in NMJ architecture are rescued by presynaptic 
expression of the respective wild-type gene. Fourth, HSPC300 genetically interacts with another 
subunit of the WAVE/SCAR complex. Fifth, HSPC300 physically associates with CYFIP and SCAR.
Conclusion: Present data provide the first evidence for HSPC300 playing a role in nervous system 
development and demonstrate in vivo that this small protein works in the context of the WAVE/ 
SCAR complex.
Background
The evolutionarily conserved WAVE/SCAR complex has 
emerged as an important Rac1 small GTPase downstream 
effector that regulates several aspects of neuronal architec­
ture. The mammalian WAVE/SCAR complex is composed 
of five proteins: CYFIP (PIR121 or Sra1), Kette (Nap1 or 
Hem2), Abi (or Abl interactor), SCAR (WAVE) and
HSPC300 [1,2]. Whereas in the mouse nervous system 
WAVE function has so far been analyzed exclusively [3,4], 
Drosophila mutants are available for all but one subunit, 
HSPC300 [5-9]. Although our understanding is still far 
from complete, studies of these mutants and their protein 
partners have already uncovered that the WAVE/SCAR 
complex acts as a crucial hub, integrating and regulating
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various signaling pathways. The SCAR protein, probably 
the best-studied subunit, is a direct activator of the Arp2/ 
3 actin nucleating complex [2,10], which is required for 
the formation of a branched actin network [11]. The other 
complex subunits physically interact to form the WAVE/ 
SCAR complex but also associate with distinct proteins 
and control specific pathways. CYFIP is a direct Rac1 effec­
tor and signals to the Fragile X mental retardation protein 
(FMRP) [7,12,13], a regulator of local protein translation 
that controls, among other targets, key players of the actin 
machinery [14-16]. CYFIP and Kette both associate with 
the SH2 SH3 adapter protein Nck/DOCK [17,18].
Despite these diverse protein partners, loss of function 
phenotypes for SCAR, CYFIP and Kette in the nervous sys­
tem are remarkably similar, if not even identical [8,19]. 
These phenotypes include defects in axon growth, branch­
ing and pathfinding, as well as abnormal growth and mor­
phology of neuromuscular junctions (NMJs), a fly model 
system for synaptic plasticity [6-9,19,20]. Since it was 
found that mutations in any one of the three fly proteins 
leads to instability of its partners [8], consistent with data 
in cellular systems or other organisms [21-25], these phe­
notypes are most likely the result of multiple corrupted 
pathways normally associated with the three proteins.
HSPC300 (haematopoietic stem/progenitor cell protein 
300), a small protein of 8 kDa, is the most conserved sub­
unit o f the SCAR/WAVE complex and has recently come 
into focus for its essential role in plant cytoskeleton 
remodeling [26,27]. Mutations in Brickl, one of the Arabi- 
dopsis HSPC300 orthologs, cause morphological defects 
that are associated with loss of cortical F-actin enrichment 
and that are in agreement with a role for HSPC300 in pro­
moting Arp2/3 complex activity [26-28]. While these data 
support a crucial role of HSPC300 in plant actin remode­
ling, others have shown that HSPC300 in vitro is neither 
required for assembly of the SCAR/WAVE complex [29] 
nor impacts on Arp2/3-dependent actin polymerization
[22]. Also, RNA interference (RNAi)-mediated knock­
down of HSPC300 in cultured Drosophila cells results in a 
reduction of cortical F-actin and alterations in cell mor­
phology that are much weaker than those resulting from 
RNAi-mediated ablation of all other four subunits [23]. 
Altogether, these observations make it difficult to predict 
the importance of HSPC300 in the animal kingdom and 
its role as a subunit o f the WAVE/SCAR complex. This is 
particularly relevant given the observation that vertebrate 
HSPC300 interacts with both SCAR and Abi, a subunit of 
the WAVE/SCAR complex that also interacts with and reg­
ulates WASP, another activator of Arp2/3 [29-31].
We here characterize HSPC300 in an animal model, with 
particular focus on nervous system development. Loss of 
HSPC300 recapitulates all aspects of nervous system
defects characterizing SCAR, CYFIP and Kette mutants, 
but notably does not lead to abnormal cell fate choices in 
sensory organs, an Abi and WASP related function [5,9]. 
This result, together with genetic and biochemical interac­
tion data, clearly demonstrates the importance of 
HSPC300 in the nervous system as well as its role in func­
tion and integrity of the WAVE/SCAR complex.
Results
H S P C 3 0 0  accum ulates in axons o f  the central nervous 
system
A putative ortholog of the mammalian HSPC300 subunit 
o f the WAVE/SCAR complex is annotated in FlyBase as 
CG30173. Using the available sequence information, we 
cloned Drosophila HSPC300 by RT-PCR and found it to be 
identical to the predicted gene sequence. In order to assess 
the expression profile of HSPC300, we performed quanti­
tative real time RT-PCR on total RNA extracted from dif­
ferent developmental stages and determined that 
HSPC300 transcripts are present throughout the fly life 
cycle. Normalization against a housekeeping gene coding 
for ribosomal protein rp49 indicates that the levels of 
HSPC300 transcripts progressively increase during devel­
opment (Figure 1a) and are particularly high in adult 
males and females. Transcript accumulation in ovaries is 
in line with high levels of HSPC300 RNA detected by in 
situ hybridization in embryos prior to onset of zygotic 
gene expression (data not shown).
A polyclonal antibody raised against the HSPC300 pro­
tein reveals a single band at the predicted molecular 
weight (8 kDa) in a western blot on Drosophila S2 cell 
extracts. Signal specificity was demonstrated first, upon 
transient HSPC300 overexpression, which induces signifi­
cant enhancement of the 8 kDa band intensity (Figure 
1b), and second, by loss of immunoreactivity in HSPC300 
mutant extracts (see below). In embryos, HSPC300 pri­
marily accumulates in the central nervous system (CNS), 
most prominent labeling localizing in axons along longi­
tudinal tracts and commissures (Figure 1c). This expres­
sion pattern perfectly matches those previously reported 
for other components of the WAVE/SCAR complex [7,8]. 
Immunolabeling specificity was further confirmed by loss 
of immunoreactivity in HSPC300 mutants (see below).
Generation o f  H S P C 3 0 0  mutants
To address the role of HSPC300, we generated loss of 
function mutants. The EP(2R)0506 line harbors a P ele­
ment on the right arm of the second chromosome at posi­
tion 60B4 and is 100% homozygous viable. The P 
element lies 75 bases upstream of the HSPC300 start 
codon (ATG), and in the right orientation to drive 
HSPC300 gene expression (Figure 2a). HSPC300 is 
flanked by two genes for which no mutant strain is
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reported, CG3163, located 263 bases upstream, 
PebIII, located 497 bases downstream (Figure 2a).
and
F ig u re !
HSPC300 expression profile. (a ) Quantitative analysis of 
HSPC300 mRNA levels by light cycler at indicated develop­
mental stages. Quantification is relative to the housekeeping 
ribosomal protein 49 (rp49) mRNA. Bars indicate SEM. ApF: 
After puparium formation. (b) Western blot analysis on pro­
tein extracts prepared from the Drosophila S2 cell line (S2 
extract), using anti-HSPC300 antibody (HSPC300). The right 
lane represents equivalent amounts of protein extract from 
the S2 cell line, which transiently overexpresses HSPC300 
upon transfection (S2 extract + HSPC300). ß-tubulin (ß-tub) 
represents a loading control. (c) HSPC300 immunolabeling 
of a whole mount embryo at stage 16; ventral view, anterior 
to the left. HSPC300 shows specific accumulation in CNS 
longitudinal connectives and commissures. The arrow and 
arrowheads show midline and motor neuron labeling, 
respectively. Scale bar: 50 |im.
We generated HSPC300 alleles by imprecise excision of 
the EP(2R)0506 P element and recovered 116 independ­
ent excision events. Among them, four lines are 
homozygous lethal at late pupal stage and fail to comple­
ment each other. These excision alleles were characterized 
by PCR and sequencing in order to identify the break­
points. In three of them, the entire HSPC300 coding 
sequences are deleted, as well as part of the neighboring 
PebIII gene (Figure 2b and data not shown). The fourth 
lethal excision line, HSPC300A543, shows unaffected 
PebIII and CG3163 genes as well as the presence of an 
intact P element. In this line, the P element is unable to 
drive expression of HSPC300 as is the case with the origi­
nal EP(2R)0506 line. To figure out the molecular lesions 
associated with this allele, we performed 3' and 5' inverse 
PCR. This confirmed the presence of intact junctions 
between the P element and surrounding genomic regions 
and revealed that the 3' end of the P element is flanked by 
a stretch of 208 bases of HSPC300 sequences followed by 
an insertion of unrelated sequences into the HSPC300 
intron (see Figure 2b for schematic representation and 
Additional file 1 for molecular characterization of 
HSPC300A543). We characterized this allele further by RT- 
PCR and detected PebIII and CG3163, but no HSPC300 
transcripts (Figure 2c), indicating that the modified 
HSPC300 transcript is either not transcribed or very rap­
idly degraded. Thus, HSPC300A543 represents a null allele 
that does not affect neighboring genes. This line was fur­
ther used to characterize the mutant phenotypes and is 
referred to as HSPC300 unless otherwise indicated.
To provide formal evidence that excision line lethality is 
specifically due to loss of HSPC300, we generated UAS- 
HSPC300 transgenic animals and performed rescue exper­
iments. Lethality observed in HSPC300A543 and 
HSPC300A961 lines is indeed rescued by HSPC300 re­
expression using either actin-Gal4 or elav-Gal4 drivers 
(ubiquitous and pan-neuronal expression, respectively, 
data not shown). Altogether, these analyses demonstrate 
that HSPC300 is an essential gene required in the nervous 
system, its zygotic depletion inducing lethality prior to 
eclosion.
H S P C 3 0 0  is m aternally contributed and is required for  
em bryonic C N S  axon m orphology
The prominent axonal localization of HSPC300 and phe­
notypes previously reported for mutations in other com­
ponents of the WAVE/SCAR complex [6-9] suggested a 
role for HSPC300 in axonogenesis. We therefore analyzed 
the integrity of the embryonic axonal network by immu- 
nolabeling with anti-FasII, which specifically recognizes 
six longitudinal fascicles of the CNS and motor axons, as
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Figure 2
HSPC300 locus and mutants. (a) Exon/intron organization and resulting transcripts are shown for the genes PebIII, CG3163 and 
HSPC300. ATG  and Stop (in grey) indicate open reading frames. EP indicates the P element insertion in the EP(2R)0506 line and 
UAS indicates the upstream activating sequence contained in the P element. (b) Molecular characterization of three excision 
lines. Line HSPC300A961 (as well as non-depicted HSPC300A521, HSPC300A3L1 alleles) represent an excision event affecting the 
entire HSPC300 gene and part of the PebIII gene. Line HSPC300A543 displays intact adjacent genes (PebIII and CG3163) and P ele­
ment. The red line represents integrated HSPC300-unrelated sequence, and the dotted line represents uncharacterized 
sequence. (c) RT-PCR on the wild-type (wt) and the HSPC300A543 excision line. The left three lanes show products obtained 
from wild-type third instar larvae; the right three lanes show product obtained from HSPC300A543 larvae. Note that HSPC300 
transcripts are detected in the wild type (third lane from the left), but not in HSPC300A543 larvae (sixth lane from the left). In 
contrast, both PebIII (fourth lane from the left) and CG3163 (fifth lane from the left) transcripts are detected in the wild type 
and in mutant larvae.
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well as with anti-BP102, which reveals connectives and 
commissures [32,33] (Figure 3). In contrast to the results 
obtained with CYFIP, SCAR and Kette mutants, complete 
loss of zygotic HSPC300 (HSPC300A543 and 
HSPC300A961) does not induce any prominent axon 
defect (Figure 3c,d). We speculated that maternal 
HSPC300 contribution compensates for loss of zygotic 
gene function, masking an essential requirement during
embryogenesis. To test this hypothesis, we generated 
homozygous HSPC300A543 mutant clones within the 
germ line of heterozygous females. Deletion of both 
maternal and zygotic HSPC300 components leads to 
severe, though variable, nervous system defects ranging 
from broken and disorganized longitudinal connectives 
to remnants of axons or depletion of all CNS axon bun­
dles (Figure 3i,j). Moreover, upon depletion of both
HSPC300
zygotic
null
F H
71
. j ® .  ■
71
zygotic null,
maternal hypomorph
M
Figure 3
HSPC300 is maternally provided and is required in the morphology of embryonic CNS. (a-j) Embryos of indicated genotypes 
labeled with the axon-specific FasII and BP102 antibodies. All images show a portion of the ventral nerve cord (ventral views, 
anterior to the top) of stage 16/17 embryos. In wild-type embryos, anti-FasII reveals six longitudinal bundles (a), and BP102 two 
commissural bundles (b) in each segment. (c,d) HSPC300 embryos show CNS axon morphology that appears wild type. (e-h) 
Embryos that lack the HSPC300 zygotic component and are maternal hypomorphs show abnormal midline crossing (arrow­
head) (e). In the most severe cases (g), axons ectopically cross the midline several times. (f,h) Commissures and longitudinal 
connectives are not properly formed (arrows). (i,j) Embryos that completely lack zygotic as well as maternal HSPC300 compo­
nents show strongly disturbed CNS development, broken longitudinal connectives and commissures (asterisks). Scale bar: 20 
|im. (k-m ) Comparative analysis of HSPC300 expression in embryos of indicated genotypes; ventral views of stage 16 
embryos, anterior to the left, anti-HSPC300 labeling. This experiment indicates that HSPC300 is maternally contributed and 
confirms the specificity of antibody. Scale bar: 50 |im.
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maternal and zygotic HSPC300 components, lethality is 
shifted to embryonic stages and embryos appear overall 
disorganized. Identical observations were made using 
other HSPC300 alleles, such as HSPC300A961 (data not 
shown).
The observed strong and pleiotropic defects did not allow 
us to score for specific neuronal requirement. We there­
fore aimed at reducing HSPC300 maternal dose without 
completely deleting it, using insertion line EP(2R)0506, 
referred to as HSPC300EP0506 from now onwards. This line 
represents a hypomorphic allele since HSPC300EP0506/  
HSPC300A543 embryos show 30% viability (versus 100% 
viability for HSPC300EP0506, and 0% viability for 
HSPC300A543). HSPC300EP0506/HSPC300A543 females 
were mated to heterozygous HSPC300A543 males. 
Amongst the progeny, we indeed noticed embryos with 
low maternal HSPC300 dose, reflected by reduced axonal 
HSPC300 immunolabeling in comparison with that 
observed in wild-type or zygotic null HSPC300 embryos 
under the same confocal microscope settings (Figure 3 k­
m). The resulting reduction in maternal HSPC300 dose 
produces embryos that overall show normal morphology 
(in contrast to those that are completely devoid of mater­
nal HSPC300), allowing us to examine late CNS develop­
ment. The embryonic phenotypes observed in this mutant 
condition, designated as maternal hypomorph, are simi­
lar, but of lower penetrance compared to those shown by 
other members of the WAVE/SCAR complex (midline 
crossing in 10% of embryos (n = 100) compared to 79% 
in CYFIP embryos (n = 150) [7]) (Figure 3e,g). Additional 
defects shared by mutants affecting the other subunits of 
the WAVE/SCAR complex [8] are disorganized fascicles, 
improper separation of commissures and broken longitu­
dinal bundles (Figure 3e-h). Taken together, these data 
clearly implicate HSPC300 in axonogenesis, presumably 
through regulation of actin cytoskeleton remodeling by 
SCAR- and Arp2/3-dependent mechanisms. They moreo­
ver indicate that the HSPC300 maternal component is suf­
ficient to sustain development in embryos that are devoid 
of zygotic HSPC300.
H S P C 3 0 0  regulates synaptic m orphology at the N M J
In addition to the embryonic axonal defects, mutations in 
other subunits of the WAVE/SCAR complex lead to synap­
tic defects that are characterized by size reduction of the 
NMJ and by supernumerary buds on pre-existing boutons 
[7,8,19]. The fact that HSPC300 as well as CYFIP, SCAR 
and Kette mutants show similar embryonic axonal defects 
prompted us to examine the structures of synaptic termi­
nals in HSPC300 larvae.
NMJs were labeled using anti-Disc Large antibody, a pre­
ferred marker to reveal NMJ morphology [7,8,34]. NMJs 
of HSPC300 larvae are severely reduced in length and dis­
play supernumerary buds (Figure 4d-h) compared to 
those of wild-type animals, those of rescued animals or 
those observed in a precise excision line (Figure 4a-c,g,h). 
The latter represents a revertant as it displays the same 
genetic background as that of imprecise excision lines 
(Figure 4g,h).
To quantitatively assess synaptic HSPC300 phenotypes, 
we measured total length of synaptic terminals using a 
computer-assisted program [7] and counted buds per syn­
aptic terminal. We focused our analysis on muscle 4 in 
abdominal segments A2-A4, innervated by the inter-seg­
mental nerve (ISN). Since NMJ growth varies in propor­
tion to muscle size [35], we normalized the total length of 
each synapse with its corresponding muscle surface area. 
Normalized synapse length of HSPC300 larvae corre­
sponds to 66% of the wild-type NMJ length, a statistically 
highly significant difference (1.36 x 10-3 ± 0.11 |im-1 ver­
sus 2.06 x 10-3 ± 0.137 |im-1 (mean ± standard error of the 
mean (SEM)); p < 0.001). Likewise, there is 88% increase 
in the bud number compared to wild type (6.42 ± 0.60 
versus 3.51 ± 0.39 (mean ± SEM); p < 0.001) (Figure 4g,h). 
Strong labeling with active zone-specific antibody NC82, 
which recognizes the Bruchpilot protein [35,36], indicates 
that HSPC300 synapses are functional (Figure 4i-n ). 
Interestingly, compared to wild-type NMJs, in which 
NC82 labeling preferentially localizes at boutons, mutant 
NMJs show uniform labeling. This is in line with the find­
ing that the characteristic bead string structure of NMJs is 
not preserved in HSPC300 larvae, in which boutons can­
not be easily identified. This phenotype is shared by muta­
tions affecting the other subunits of the WAVE/SCAR 
complex [7,8,37] and may be related to the supernumer­
ary budding phenotype.
Finally, NMJ phenotypes are rescued by elav-Gal4-driven 
HSPC300 expression but not by postsynaptic HSPC300 
expression induced by the muscle-specific mhc-Gal4 driver 
(Figure 4g,h, and data not shown). Taken together, these 
results reveal that HSPC300 is required by motoneurons 
for synaptic morphogenesis.
H S P C 3 0 0  in the context o f  the W AVE/SCAR co m plex
The phenotypic similarity of axonal and synaptic architec­
ture of HSPC300, CYFIP, Kette and SCAR mutants strongly 
suggests synergy amongst the wild-type molecules and 
indicates that HSPC300 represents a functional subunit of 
the Drosophila WAVE/SCAR complex in vivo. To provide 
evidence for the physical association of HSPC300 and the 
other WAVE/SCAR complex subunits, we performed co- 
immunoprecipitation experiments in Drosophila S2 cells. 
Both CYFIP and SCAR proteins were found to co-immu- 
noprecipitate with HSPC300 (Figure 5a), as revealed by 
using anti-CYFIP (band at 145 kDa) and anti-SCAR (68 
kDa) antibodies [7,9]. Control experiments performed in
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Figure 4
HSPC300 controls synaptogenesis at NMJs. (a-f) Anti-Disc Large immunolabeling of muscle 4 synaptic terminals of third instar 
larvae of the following genotypes: (a-c) wild type; (d-f)HSPC300. Compared to the wild type (WT), HSPC300 NMJs are shorter 
and display supernumerary buds. Insets in (a,d) show high magnifications of marked regions; (c,f) represent high magnifications 
of marked regions in (b,e), respectively. Arrows indicate buds. Scale bar: 20 |im (a,d); 14 |im (b,e); 8 |im (c,f). (g,h) Statistical 
evaluation of the NMJ phenotype of the following genotypes: wild type (WT); HSPC300 (HSPC300a54-3); HSPC300 heterozygous 
(HSPC300a543I+); Revertant, precise excision event (h SPc300861 ); and Rescue (elav-Gal4; UAS-HSPC300, HSPC300a543). (g) 
Length of synaptic terminals (|im) normalized over respective muscle surface area (|im2). (h) Number of buds per synapse. The 
sample size (number of muscle 4 junctions scored) was 25 per genotype. Error bars indicate SEM. Statistical significance (p) was 
calculated using AN O V A  and post hoc analysis (see Materials and methods). Asterisks indicate p-value; *p < 0.05; ***p < 0.0001. 
(i-n) Wild type (i-k) and HSPC300 (l-n) NMJs labeled with anti-Disc Large (DLG; green) and active zone-specific marker NC82 
antibody (red). Arrows indicate the region of low NC82 accumulation located between boutons, and arrowheads the supernu­
merary buds in the mutant synapse. Scale bar: 20 |im (i,j,l,m); 4 |im (k,n).
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parallel with unrelated rabbit IgG did not co-immunopre- 
cipitate either of these proteins, thus confirming the spe­
cificity of the observed interactions. Thus, Drosophila 
HSPC300 appears to represent, like its mammalian coun­
terpart, a subunit o f the WAVE/SCAR complex.
We and others have previously demonstrated that CYFIP, 
Kette and SCAR are essential for the integrity and the sta­
bility of the WAVE/SCAR complex in vivo. If any of them 
is missing, the other subunits fail to be detected [8,21-25], 
most likely due to proteasome-mediated degradation
[23]. In line with the observation that zygotic HSPC300 
null embryos show neither significant reduction of 
HSPC300 labeling (Figure 3l) nor axonal defects (Figure 
3c,d), other WAVE/SCAR complex proteins (SCAR and 
CYFIP) accumulate at wild-type levels in these embryos 
(Additional file 2). In order to determine the stabilizing 
potential o f HSPC300, we therefore assessed the levels of 
CYFIP and SCAR later in development, in third instar 
HSPC300 mutant larvae, a developmental stage in which 
maternal contribution has faded. Indeed, we noticed a 
considerable decrease in CYFIP, Kette, SCAR and Abi pro­
tein levels compared to those observed in wild-type lar­
vae. Qualitatively similar results were obtained in zygotic 
null larvae and in larvae that completely lack the zygotic 
component and also are maternal hypomorphs, even 
though the latter genotype shows a stronger defect (Figure 
5b). Interestingly, there appears to be yet stronger reduc­
tion of these proteins in the extracts prepared from CYFIP 
zygotic null animals (Figure 5b).
To provide formal evidence that HSPC300-induced phe­
notypes depend on its functional relation with the WAVE/ 
SCAR complex, we performed genetic interaction experi­
ments at the NMJ. We took advantage of our previous 
observation that single mutations in the subunits of the 
WAVE/SCAR complex show reduced synapse length in a 
dose-dependent manner. Heterozygous mutants indeed 
already show significantly reduced synaptic length [8] 
(Figure 4g). Interestingly, while double heterozygous 
HSPC300, CYFIP NMJs are similar to those from larvae 
that are heterozygous for either gene, imbalance between 
HSPC and CYFIP content using a sensitized background 
results in a marked further decrease of synaptic terminal 
length: the strong CYFIP transheterozygous allelic combi­
nation CYFIPA851/CYFIPEP3267 (that is, null over hypo- 
morph), in an otherwise heterozygous HSPC300 
background, leads to a significant reduction in the syn­
apse length (Table 1). This result indicates that HSPC300 
and CYFIP synergistically affect synapse growth and pro­
vides a first assessment of the molecular pathway requir­
ing HSPC300.
The above data clearly demonstrate that HSPC300 ani­
mals share nervous system defects with SCAR, CYFIP and
Figure 5
Protein levels of W AVE/SCAR complex subunits in different 
mutant contexts. (a) Immunoprecipitation experiments in 
Drosophila S2 cytoplasmic cell extracts using the anti- 
HSPC300 antibody. From left to right: anti-HSPC300 immu­
noprecipitation, IgG immunoprecipitation, input (cytoplasmic 
extract). Proteins are indicated to the right, corresponding 
molecular weights to the left. (b) Quantitative analysis of 
CYFIP, Kette, SCAR, Abi and HSPC300 protein levels by 
western blot on third instar larval extracts of the following 
genotypes: wild type (WT); HSPC300 zygotic null; HSPC300 
zygotic null and maternal hypomorph; CYFIP zygotic null. Pro­
teins are indicated to the right, corresponding molecular 
weights to the left. ß-tubulin represents a loading control.
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T a b le  1: G en e tic  in teraction s at NM Js
Genotype Mean Synapse length ± SEM (^m) P-values
W ild type 
HSPC300a543/+
CYFIPa851/+  
CYFIPa85.i ICYFIPep3267 
HSPC300a543/+; CYFIPa851/+  
HSPC300a543/+; 
CYFIPa851ICYFIPEP3267
87.46 ± 2.28 
78.48 ± 3.88 
78.83 ± 2.92 
68.18 ± 3.18
80.47 ± 2.52 
62.00 ± 2.69
PWild type< 0.05 
PWild type< 0.05
PCYFIP/CYFIPEP3267~0.I42
The sample size per genotype in all cases was 25. P-values versus indicated genotypes (superscript) were determined by Student's t-test.
Kette mutants. Flies mutant for subunits of the WAVE/ 
SCAR complex are also characterized by misshaped mac- 
rochaetae [5,19,20], a phenotype due to defects in F-actin. 
The phenotype of bent bristles is also observed in 
HSPC300 pharate adults (Figure 6, arrows). However, 
specification of sensory organ precursors (SOPs) is not 
affected and the number of bristles on the head and tho­
rax are normal (Figure 6), as in mutant SCAR and CYFIP 
conditions [9] (our unpublished data). This result is par­
ticularly interesting in view of the observation that 
HSPC300 also directly interacts with Abi [29], which in 
turn interacts with and activates WASP [5,30]. The Abi- 
WASP biochemical interaction is further sustained by the 
common phenotype of WASP and knockdown Abi 
mutant flies, which lack macrochaete on the thorax, due 
to SOP cell fate defects [5,20]. On the basis of the pheno­
typical similarity, we conclude that loss of HSPC300 
affects signal transduction through SCAR, not WASP.
Discussion
The evolutionarily conserved WAVE/SCAR complex is 
known to regulate the actin nucleating Arp2/3 complex in 
a Rac-dependent manner [1,2,7,8,23,27,38]. While the 
functions of most components of this complex have been 
extensively explored, the role of the small protein 
HSPC300, although one of the complex core subunits, is 
less understood. Here, we present the first functional anal­
ysis of HSPC300 in an animal model and demonstrate the 
importance of this protein in nervous system develop­
ment and connectivity.
H S P C 3 0 0  functions within the R acl-W A V E/SC A R  
com plex-Arp2/3 pathw ay
The SCAR, CYFIP, Kette and Abi subunits of the WAVE/ 
SCAR complex have been shown to impact on various 
processes and structures that depend on actin cytoskeletal 
remodeling. These include Dictyostelium motility [21], 
development of plant trichomes [27], as well as egg cham­
ber structure and nuclear positioning in the blastoderm of 
Drosophila [9]. Crucial for the versatile functions of the 
complex is its structural integrity. Loss or mutations in any 
subunit (CYFIP, Kette or SCAR) leads to proteasome- 
mediated degradation of the others and, as a conse­
quence, identical mutant phenotypes [8,21,23]. Surpris­
ingly, HSPC300 knockdown in Drosophila S2 cells has 
been reported to produce much milder cytoskeletal phe­
notypes than those produced by targeting other compo­
nents of the WAVE/SCAR complex [23]. In addition, in in 
vitro experiments, lack of HSPC300 affects neither com­
plex assembly [29] nor the complex's ability to activate 
Arp2/3 in vitro [22], two features that characterize other 
complex subunits. These data raise questions as to the real 
role of HSPC300 in the context of the WAVE/SCAR com­
plex.
Presented data demonstrate that Drosophila HSPC300 
constitutes a subunit of the WAVE/SCAR complex in vitro 
and in vivo. Like the other subunits of the complex, 
HSPC300 is highly expressed in the developing fly nerv­
ous system and is crucially required for axonogenesis and 
neuromuscular synapse morphogenesis. Moreover, 
HSPC300 loss of function conditions are marked by a 
decrease in all members of the WAVE/SCAR complex, a 
result that is in keeping with a model in which each sub­
unit, including HSPC300, significantly contributes 
towards the stability of the complex, notably in vivo. By 
using HSPC300 allele combinations that lead to different 
amounts of HSPC300 protein, we have revealed that a 
sharp threshold exists and that the maternal component is 
sufficient to ensure normal embryonic development and 
viability. The stringent genetic conditions we generated 
(loss of zygotic in addition to partial or complete loss of 
maternal HSPC300) also allowed us to reveal that strong 
loss of HSPC300 protein is necessary to cause dramatic 
consequences comparable to those observed in mutants 
affecting other complex components, thereby suggesting 
that the previously obtained mild phenotypes (RNAi- 
mediated knockdown in cells [23]) merely result from the 
limitation of the utilized technique. Thus, highly similar 
requirements for HSPC300 and the WAVE/SCAR complex 
components control cell morphology in CNS neurons 
and at NMJs.
The genetic interaction observed upon disrupting the bal­
ance between CYFIP and HSPC300 levels shows a posi­
tive/synergistic role for HSPC300 in the Rac1-WAVE/
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A  wt HSPC300
Figure 6
HSPC300 Bristle phenotype. (a) Scanning electron microscope images of the dorso-posterior portion of the Drosophila head 
and (b) light microscope images of thoracic bristles. On the left are wild-type (wt), and on the right HSPC300 pharate adults. 
Occasionally, bristles in HSPC300 pharate adults show typical bent morphology (arrows). Note that HSPC300 pharate adults 
display normal specification of sensory bristles on the head, notum and scutellum. Scale bars: 100 |im.
SCAR complex pathway to control synapse length, 
thereby providing first genetic evidence for HSPC300 
functioning in this pathway. Taken together, the pheno­
types and genetic interactions in the fly nervous system, as 
well as the phenotypes previously described in Arabidopsis 
[26,27], provide strong evidence for HSPC300 being an 
evolutionarily important integral part of the Rac1-WAVE/ 
SCAR-Arp2/3 pathway.
Interestingly, it has been shown that the control of cotyle­
don cell size requires Arabidopsis Brick1 but not WAVE/ 
SCAR-Arp2/3 [27], suggestive of an additional function 
that does not depend on the WAVE/SCAR complex. These 
data are in line with the existence of a significant fraction
of free and soluble vertebrate HSPC300 and with our find­
ing that phenotype and genetic interactions can only be 
revealed upon strong HSPC300 depletion and imbalance, 
respectively. Whether HSPC300, similar to CYFIP, Kette 
and Abi, works on additional pathways that are independ­
ent of the WAVE/SCAR complex remains to be elucidated. 
Since HSPC300 is the most conserved subunit of the 
WAVE/SCAR complex not only in the animal kingdom 
and Dictyostelium, but also in plants, and since no 
HSPC300 paralogous gene exists in flies, we expect our 
data to be of predictive value for HSPC300 indispensabil­
ity with respect to the function of its associated complex 
in other organisms. We further expect the generated
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mutant animals to facilitate identification of novel 
HSPC300-dependent pathways.
Conclusion
We present the first evidence that the small protein 
HSPC300 is an indispensable component of the WAVE/ 
SCAR complex and plays an important role in nervous 
system development in Drosophila. Moreover, accumulat­
ing data suggest that signaling of the small Rho GTPase 
Rac1 through the WAVE/SCAR complex is implicated not 
only in structural connectivity in fly [5-9] (this study) and 
mouse [3,4] brain, but is also involved in higher cognitive 
functions and human disease when mutated. Mutations 
in at least a dozen genes associated with mental retarda­
tion in humans directly regulate/mediate Rho GTPase 
function or may be connected to their associated signaling 
pathways (reviewed in [39-42]). This notably includes 
two genes the products of which directly associate with 
the WAVE/SCAR complex: FMRP [7,8,13] and a GTPase 
activating protein termed MEGAP/WRP/srGAP3 [43,44]. 
These findings emphasize the dominant role of this com­
plex not only in architecture but also in higher functions 
of the nervous system. Moreover, they place the WAVE/ 
SCAR complex in a central position to genes that are 
highly relevant to cognitive functions. Based on present 
data, we propose that HSPC300 is a new promising candi­
date gene for genetic causes underlying impaired cogni­
tion. Whereas final evidence for the role of HSPC300 in 
mammal cognition awaits the characterization of 
HSPC300 mouse knockout phenotypes, a WAVE knock­
out mouse does indeed show learning and memory 
defects [43,44] and altered synaptic plasticity [4].
M aterials and m ethods  
Genetics
The wild-type strain used was Sevelen. Line EP(2R)0506 
was provided by the Szeged Stock Center (Szeged, Hun­
gary), and elav-Gal4 (C155) by the Bloomington Stock 
Center (Bloomington, Indiana, USA). HSPC300 excision 
mutants were obtained upon transposon mobilization in 
the EP(2R)0506 line after isogenization. Transgenic lines 
were obtained using standard protocols. UAS-HSPC300 
(line 4b.1) was recombined onto the HSPC300A543 carry­
ing chromosome. FRT42B was recombined separately 
with HSPC300A543 and HSPC300A96. Germ line clones 
were induced in hs-FLP; FRT42B OvoD/FRT42B, 
HSPC300A543 flies as described [45]. Other utilized strains 
were CYFIPA851, Kette03335 and SCARA37 [8].
M olecular techniques
DNA constructs
HSPC300 coding sequence was amplified by RT-PCR on 
total RNA extract from Drosophila S2 cells. Utilized prim­
ers were GGG GAA TTC AAA GAT GAG TGG GGC TCA 
CAG and GGG CTC GAG CGT TTA CGT TAA TGT TTC
ACC CTG. After Eco RI, XhoI digestion, the fragment was 
cloned into pGEM-T and pUAST vectors.
Quantitative mRNA analysis
Total RNA was recovered from animals of the indicated 
developmental stage or tissue and subjected to cDNA syn­
thesis using primers mentioned above. Real time PCR was 
performed according to standard protocols with a Light 
Cycler (Roche, Basel, Switzerland) using primers AAA 
GCA GAT CCA CCA GGA CT and CGC TCC AGG ATC 
GTT AGT TT. Primers for housekeeping gene rp49 were 
GCG CAC CAA GCA CTT CAT C and GAC GCA CTC TGT 
TGT CGA TAC C. All samples were analyzed in replicates 
of four.
5' and 3' Inverse PCR
Total genomic DNA of HSPC300A543 flies was extracted by 
standard methods, digested with MspI and EcoRI, fol­
lowed by self ligations in separate reactions. MspI severed 
within the P element and flanking 3' sequence, resulting 
in rescue of the 3 ' end. EcoRI severed within the P element 
and flanking 5' sequence, resulting in rescue of the 5' end. 
The rescued ends were amplified by standard primer com­
bination of GTA ACG CTA ATC ACT CCG AAC AGG TCA 
CA and CAA TCA TAT CGC TGT CTC ACT CA. Amplified 
products were subsequently sequence verified by ACA 
CAA CCT TTC CTC TCA ACA A for the 5 ' end and GAC 
ACT CAG AAT ACT ATT C for the 3' end.
Immunolabeling on embryos and larvae 
Immunolabeling on embryos was performed according to 
standard procedures. Larvae open-book preparations and 
immunolabeling are described in Bellen and Budnik [46]. 
Antibodies utilized were: polyclonal HSPC300 antibody 
(1:1,000), anti-Fas II ID4 (1:50) and anti-Disc large (1:20) 
(Developmental Studies Hybridoma Bank, Iowa City, 
USA), anti-GFP (1:50; Santa Cruz Biotechnologies (Santa 
Cruz, California, USA), anti-SCAR [9] (1:100) and anti- 
CYFIP [8] (1:100).
Immunoprecipitations
S2 cells were cultured in Schneider cell medium (Gibco 
BRL/Invitrogen, Karlsruhe, Germany) + 10% fetal calf 
serum. Cytoplasmic extracts were prepared by lysing S2 
cells in buffer (200 mM NaCl, 20 mM Tris-HCl pH 7.5, 5 
mM MgCl2, 0.4% Triton X-100, protease inhibitor cock­
tail (PIC)), kept on ice for 10 minutes. The 2,000 g super­
natant was incubated for 6 h with 5 |ig of either anti- 
HSPC300 or rabbit IgG and protein A Sepharose. Beads 
were extensively washed in lysis buffer, directly boiled in 
SDS-PAGE loading buffer and subjected to SDS-PAGE 
analysis.
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Embryonic and larval extracts
Animals of the correct genotype were collected on the 
basis of labeled balancer chromosomes. Embryonic 
extracts were prepared from overnight (18 h) cages. 
Embryos and wandering third instar larvae were mashed 
using pestles in 150 mM NaCl, 20 mM Tris-HCl pH 7.5, 1 
mM EDTA, 0.1 mM MgCl2, 1% Triton X-100, PIC, fol­
lowed by an incubation on ice for 10 minutes. The super­
natant of a 12,000 g centrifugation was briefly sonicated, 
and the amount of total protein was determined by Brad­
ford assay.
Western blot analysis
Proteins were separated in 7% polyacrylamide gels. For 
detection of HSPC300, proteins were resolved on precast 
4 -12%  Bis-Tris polyacrylamide gels (Invitrogen, Karl­
sruhe, Germany) in NuPAGE-MES buffer. SDS-PAGE and 
blotting were performed according to standard proce­
dures. Primary antibodies used in western blot analysis 
were anti-HSPC300 (1:3,000), anti-CYFIP #1719 (1:100), 
anti-SCAR (1:2,000), anti-Kette #2081 [8] (1:2,000) and 
anti-ß-tubulin (1:4,000) (Chemicon, Hampshire, UK).
Microscopy and statistics
The confocal microscope was a Leica TCS-SP1. Confocal 
images were assembled using in-house developed soft­
ware. Synapse images for quantification were obtained 
using a Zeiss Axiophot 2 microscope. Scanning electron 
microscopy was performed with a Philips -XL20 micro­
scope. Twenty-five NMJs (muscle 4, segments A2-A4) 
were scored per genotype. All pictures of synapses were 
taken at 40x and their corresponding muscle area pictures 
were taken at 10x and subjected to an in-house developed 
software [7,8]. Statistical significance was calculated using 
ANOVA and the Newman-Keuls method for post hoc pair­
wise analyses.
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obtained upon 5' and 3' inverse PCR (compared with original line 
EP(2R)0506) showing the presence o f intact junctions between the P ele­
ment and surrounding genomic sequences. Note that, following 208 bases 
o f the HSPC300 sequence, an unrelated sequence o f at least 74 bases is 
present.
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Additional file 2
Normal levels and localization o f other WAVE/SCAR complex proteins 
(CYFIP, SCAR) in HSPC300 zygotic null embryos. (a -f) Wild-type 
(WT), HSPC300 zygotic null and, as control, CYFIP zygotic null embryos 
labeled with anti-CYFIP (a-c) or anti-SCAR (d-f) antibodies. (g) Anti- 
CYFIP and anti-SCAR immunoblot analysis of WT and HSPC300 zygotic 
null mutant extracts. Note that in contrast to genetic conditions in which 
maternal and zygotic HSPC300 doses have been depleted, there is no 
appreciable difference in CYFIP and SCAR levels and distribution in 
HSPC300 zygotic null embryos. Maternally provided HSPC300 protein is 
thus sufficient to stabilize other WAVE/SCAR complex proteins during 
embryonic development. In contrast, despite maternal contribution, loss o f 
zygotic CYFIP destabilizes SCAR. Scale bar: 75 fjm.
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